RxLive, a St. Petersburg, FL-based provider of population health pharmacy solutions, has announced a $5 million Series A funding round. RxLive has raised a total of $8 million to date.
The round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal Health™ (NYSE: CAH), a distributor of pharmaceuticals, a global manufacturer, and a distributor of medical and laboratory products, and a provider of performance and data solutions in health care.
RxLive will use the funding to expand its engineering, analytics, and sales and marketing teams, with particular investment in the continuous improvement of its AI and the functionality of its medication management platform.
Company: RxLive, Inc.
Round: Series A
Funding Month: July 2022
Lead Investors: SpringTide
Additional Investors: Cardinal Health™ (NYSE: CAH
Company Website: https://rxlive.com/
Software Category: Medication Management platform
About the Company: Founded in 2018, RxLive serves a national customer base of healthcare providers. RxLive integrates clinical pharmacists into the healthcare team to create significant financial and clinical value. Implementing and maximizing this value is a discipline we call Value‑Based Pharmacy™. RxLive is a concierge telehealth pharmacy service that connects patients with expert pharmacists in a secure, private and personal way.